The Way Home
Release time:
2020-07-15
This Spring Festival holiday, according to our Yunnan peak work arrangement, I have been sticking to the production post. But the outbreak of the new crown virus, disrupted the original arrangements, the end of the Chinese New Year holiday I can not go home. More than a month has passed, the situation of epidemic prevention and control has improved, and we can finally go home. Of course, you have to call the person in charge of your home and community to ask about relevant matters in advance before you can embark on the road home in this special period.
On March 15, I arrived at Pu'er Airport 30 minutes earlier than usual. I took my temperature and regular security check at the entrance before entering the lobby to handle boarding passes and luggage check. Although the health code has been used all over the country, the detailed requirements for different flights are still different, so the code must be scanned and the green code must be displayed before entering the security check channel. Line up to get on the plane and go through another round of temperature checks. After everyone was seated, the stewardess introduced in detail the matters needing attention in the special period. The test procedure is repeated over and over again, which virtually brings us a little psychological pressure. After all, this is a special period.
to Kunming Changshui Airport transit, and first take the temperature, before entering the business, not only need to show the ID card, but also show the boarding pass of the last plane. When you arrive at the corresponding boarding gate, you will be prompted to apply for the flight's health code. Because there are many people at the airport, it is especially emphasized that a safe distance of more than one meter must be maintained between people when checking in and queuing. After entering the boarding corridor, you still have to take your temperature before boarding the plane. After taking your seat, the stewardess once again suggested protective measures and asked each person to fill in a paper version of the undertaking. When
arrived at Xiaoshan Airport and queued up to get off the plane, the stewardess reminded everyone that they had to handle the Hangzhou health code before they could go out. So the body temperature detection and health code were operated again. After getting out of the terminal, I found the car that my family came to pick up the plane, got on the car, and finally breathed a long sigh of relief. But what I didn't expect still happened-out of the airport expressway, there was congestion on the expressway, and a section of the road could only be driven to 40 kilometers! However, this probably proves that the resumption of work in Zhejiang is more ideal.
Back to Jinhua, arrived at the gate of the community, the staff of the prevention and control card point first came up with a "shot" (I can't remember how many times I took my temperature this day), asking where I came back from, what kind of transportation I took, and whether my body was abnormal... I also repeatedly asked to report to the community tomorrow morning. Previously, I saw the "highest treatment" with the highest frequency of access on the Internet, which was also an experience. On the morning of the 16th, I went to the community again, reported, scanned the action track code, signed a letter of commitment, and joined the community self-health testing WeChat group. In the next 14 days, I, an "outsider", must report my temperature sooner or later. However, fortunately, the body is not in any condition and the movement is still free.
In these extraordinary times, going home also becomes complicated. But because of this, homesick, go home, have a home, just have more yearning than usual, have more happiness ...... (Lou Xuxin)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31